0.00Open0.55Pre Close0 Volume660 Open Interest25.00Strike Price0.00Turnover249.63%IV22.52%PremiumMay 16, 2025Expiry Date0.00Intrinsic Value100Multiplier3DDays to Expiry0.55Extrinsic Value100Contract SizeAmericanOptions Type-0.1299Delta0.0291Gamma60.10Leverage Ratio-0.2435Theta-0.0004Rho-7.81Eff Leverage0.0062Vega
Scholar Rock Stock Discussion
Breakthrough: Scholar Rock's SMA Drug Shows 30.4% Patient Improvement in Phase 3 Trial
Scholar Rock's $437M War Chest: Can Their SMA Drug Deliver Returns for Investors?
Can This Phase 3 SMA Drug Transform Muscle Disease Treatment? Key Data Coming at MDA Conference
No comment yet